Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance

Role of YAP/TAZ in mechanotransduction

Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979 · see citing works

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151 · see citing works

Remodelling the extracellular matrix in development and disease

Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · see citing works

The biology and function of fibroblasts in cancer

Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366 · see citing works

Integrins in cancer: biological implications and therapeutic opportunities

Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,721 · see citing works

TGF-β: the master regulator of fibrosis

Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528 · see citing works

Structure and function of matrix metalloproteinases and TIMPs

Nagase, H., Visse, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,416 · see citing works

Matrix metalloproteinases and the regulation of tissue remodelling

Page, A. W., Ewald, A. J., & Werb, Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2125 · Cited by 3,011 · see citing works

EMT Transition States during Tumor Progression and Metastasis

Pastushenko, I., & Blanpain, C. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.12.001 · Cited by 2,866 · see citing works

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Zhang, Y., & Zhang, Z. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,815 · see citing works

Functions of Cell Surface Heparan Sulfate Proteoglycans

Bernfield, M. R., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J. M., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,689 · see citing works

Extracellular matrix structure

Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598 · see citing works

The Collagen Family

Ricard-Blum, S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004978 · Cited by 2,305 · see citing works

Concepts of extracellular matrix remodelling in tumour progression and metastasis

Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296 · see citing works

Extracellular Matrix Degradation and Remodeling in Development and Disease

Lu, P., Takai, K., Weaver, V. M., & Werb, Z. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005058 · Cited by 2,265 · see citing works

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195 · see citing works

Matrix metalloproteinases and tumor metastasis

Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960 · see citing works

Fibronectin at a glance

Pankov, R. G., & Yamada, K. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00059 · Cited by 1,956 · see citing works

Cancer immunoediting and resistance to T cell-based immunotherapy

O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759 · see citing works

Basement membranes: structure, assembly and role in tumour angiogenesis

Kalluri, R. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1094 · Cited by 1,748 · see citing works

Integrin-regulated FAK–Src signaling in normal and cancer cells

Mitra, S. K., & Schlaepfer, D. D. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.011 · Cited by 1,591 · see citing works

Extracellular Matrix Assembly: A Multiscale Deconstruction

Mouw, J. K., Ou, G., & Weaver, V. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3902 · Cited by 1,534 · see citing works

Mediating Tumor Targeting Efficiency of Nanoparticles Through Design

Perrault, S. D., Walkey, C., Jennings, T. L., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,516 · see citing works

Every step of the way: integrins in cancer progression and metastasis

Hamidi, H., & Ivaska, J. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0038-z · Cited by 1,493 · see citing works

The biology and role of CD44 in cancer progression: therapeutic implications

Chen, C., Zhao, S., Karnad, A. B., & Freeman, J. W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0605-5 · Cited by 1,404 · see citing works

A review of cancer immunotherapy toxicity

Kennedy, L. B., & Salama, A. K. S. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21596 · Cited by 1,376 · see citing works

Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects

Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,270 · see citing works

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans

Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,264 · see citing works

Integrin Structure, Activation, and InteractionsPreprint

Campbell, I. D., & Humphries, M. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004994 · Cited by 1,192 · see citing works

The ADAM metalloproteinases

Edwards, D. R., Handsley, M. M., & Pennington, C. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.001 · Cited by 1,165 · see citing works

Role of extracellular matrix assembly in interstitial transport in solid tumors.

Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165 · see citing works

The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development

Sorushanova, A., Delgado, L. M., Wu, Z., Shologu, N., Kshirsagar, A., Raghunath, R., Mullen, A. M., Bayon, Y., Pandit, A. S., Raghunath, M., et al. (2018) · Advanced Materials · doi:10.1002/adma.201801651 · Cited by 1,156 · see citing works

Collagen – biomaterial for drug delivery1Dedicated to Professor Dr. Eberhard Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, on the occasion of his 70th birthday.1

Friess, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00017-4 · Cited by 1,134 · see citing works

Role of Extracellular Matrix in Development and Cancer Progression

Walker, C., Mojares, E., & Hernández, A. E. D. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103028 · Cited by 1,103 · see citing works

A guide to the composition and functions of the extracellular matrix

Karamanos, N. K., Theocharis, A. D., Piperigkou, Z., Manou, D., Passi, A. G., Skandalis, S. S., Vynios, D. H., Orian‐Rousseau, V., Ricard‐Blum, S., Schmelzer, C. E. H., et al. (2021) · FEBS Journal · doi:10.1111/febs.15776 · Cited by 1,100 · see citing works

Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis

Pittayapruek, P., Meephansan, J., Prapapan, O., Komine, M., & Ohtsuki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060868 · Cited by 1,099 · see citing works

Integrin-mediated mechanotransduction

Sun, Z., Guo, S., & Fässler, R. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201609037 · Cited by 1,079 · see citing works

The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles

Park, M. V. D. Z., Neigh, A. M., Vermeulen, J. P., de la Fonteyne, L. J. J., Verharen, H. W., Briedé, J. J., Loveren, H. V., & de Jong, W. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.085 · Cited by 1,011 · see citing works

The matrix in cancer

Cox, T. R. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 989 · see citing works

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977 · see citing works

Extracellular matrix and its therapeutic potential for cancer treatment

Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962 · see citing works

Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance

Cooper, J. M., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 951 · see citing works

Collagens at a glance

Kadler, K., Baldock, C., Bella, J., & Boot-Handford, R. (2007) · Journal of Cell Science · doi:10.1242/jcs.03453 · Cited by 903 · see citing works

Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis

Zhao, X., & Guan, J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.001 · Cited by 838 · see citing works

Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes

Caruana, I., Savoldo, B., Hoyos, V., Weber, G., Liu, H., Kim, E. S., Ittmann, M., Marchetti, D., & Dotti, G. (2015) · Nature Medicine · doi:10.1038/nm.3833 · Cited by 820 · see citing works

Extracellular matrix (ECM) stiffness and degradation as cancer drivers

Najafi, M., Farhood, B., & Mortezaee, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27681 · Cited by 711 · see citing works

Fibrosis and cancer: A strained relationship

Piersma, B., Hayward, M.-K., & Weaver, V. M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188356 · Cited by 686 · see citing works

A receptor for green tea polyphenol EGCG

Tachibana, H., Koga, K., Fujimura, Y., & Yamada, K. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb743 · Cited by 682 · see citing works

Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering

Nitta, S., & Numata, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011629 · Cited by 669 · see citing works

Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

Fiori, M. E., Franco, S. D., Villanova, L., Bianca, P., Stassi, G., & Maria, R. D. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0994-2 · Cited by 648 · see citing works

Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 604 · see citing works

Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine

Mattheolabakis, G., Milane, L., Singh, A., & Amiji, M. M. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1052072 · Cited by 597 · see citing works

Collagen as a double-edged sword in tumor progression

Fang, M., Yuan, J., Peng, C., & Li, Y. (2014) · Tumor Biology · doi:10.1007/s13277-013-1511-7 · Cited by 580 · see citing works

Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology

de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D. W., Gill, S. E., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 555 · see citing works

Diffusion and Convection in Collagen Gels: Implications for Transport in the Tumor Interstitium

Ramanujan, S., Pluen, A., McKee, T. D., Brown, E. B., Boucher, Y., & Jain, R. K. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)73933-7 · Cited by 554 · see citing works

Targeting extracellular matrix stiffness to attenuate disease: from molecular mechanisms to clinical trials

Lampi, M. C., & Reinhart-King, C. A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0475 · Cited by 551 · see citing works

Emerging therapeutic opportunities for integrin inhibitors

Slack, R. J., Macdonald, S. J. F., Roper, J. A., Jenkins, G. R., & Hatley, R. J. D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00284-4 · Cited by 550 · see citing works

Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance

Erin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527 · see citing works

Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells

Rice, A. J., Cortes, E., Lachowski, D., Cheung, B. C. H., Karim, S. A., Morton, J. P., & Hernández, A. E. D. R. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.54 · Cited by 524 · see citing works

The extracellular matrix and the immune system: A mutually dependent relationship

Sutherland, T. E., Dyer, D. P., & Allen, J. E. (2023) · Science · doi:10.1126/science.abp8964 · Cited by 519 · see citing works

The good and the bad collagens of fibrosis – Their role in signaling and organ function

Karsdal, M. A., Nielsen, S. H., Leeming, D. J., Langholm, L. L., Nielsen, M. J., Manon-Jensen, T., Siebuhr, A., Gudmann, N. S., Rønnow, S., Sand, J. M., et al. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.014 · Cited by 509 · see citing works

Recombinant collagen and gelatin for drug delivery

Olsen, D. R. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.008 · Cited by 508 · see citing works

Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy

Jiang, Y., Zhang, H., Wang, J., Liu, Y., Luo, T. L., & Hua, H. M. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01252-0 · Cited by 506 · see citing works

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology

Nissen, N. I., Karsdal, M. A., & Willumsen, N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1110-6 · Cited by 492 · see citing works

Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo

Xu, J., Rodriguez, D., Petitclerc, É., Kim, J., Hangai, M., Yuen, S., Davis, G. E., & Brooks, P. C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103111 · Cited by 489 · see citing works

Collagen gel systems for sustained delivery and tissue engineering

Wallace, D. G. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.004 · Cited by 488 · see citing works

Application of hyaluronic acid as carriers in drug delivery

Huang, G., & Huang, H. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1450910 · Cited by 478 · see citing works

Hyaluronic acid: A review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies

Vasvani, S., Kulkarni, P., & Rawtani, D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.066 · Cited by 477 · see citing works

Matrix metalloproteinase interactions with collagen and elastin

Doren, S. R. V. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.005 · Cited by 463 · see citing works

Novel therapies emerging in oncology to target the TGF‐β pathway

Kim, B.-G., Malek, E., Choi, S. H., Ignatz-Hoover, J. J., & Driscoll, J. J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01053-x · Cited by 453 · see citing works

Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells

Bourguignon, L., Peyrollier, K., Xia, W., & Gilad, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800109200 · Cited by 441 · see citing works

Integrin affinity modulation

Hughes, P. E., & Pfaff, M. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01339-7 · Cited by 436 · see citing works

The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes

Wang, F., Yu, L., Monopoli, M. P., Sandin, P., Mahon, E., Salvati, A. L., & Dawson, K. A. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.04.010 · Cited by 426 · see citing works

Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility

Kaur, A., Ecker, B. L., Douglass, S. M., Kugel, C. H., Webster, M. R., Almeida, F. V., Somasundaram, R., Hayden, J. E., Ban, E., Ahmadzadeh, H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0193 · Cited by 421 · see citing works

Biomacromolecules as carriers in drug delivery and tissue engineering

Zhang, Y., Sun, T., & Jiang, C. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.005 · Cited by 417 · see citing works

Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells

Tian, C., Clauser, K. R., Öhlund, D., Rickelt, S., Huang, Y., Gupta, M. R., Mani, D. R., Carr, S. A., Tuveson, D. A., & Hynes, R. O. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908626116 · Cited by 415 · see citing works

Extracellular fluid viscosity enhances cell migration and cancer dissemination

Bera, K., Kiepas, A., Godet, I., Li, Y., Mehta, P., Ifemembi, B., Paul, C. D., Sen, A., Serra, S. A., Stoletov, K. V., et al. (2022) · Nature · doi:10.1038/s41586-022-05394-6 · Cited by 412 · see citing works

Targeting FAK in anticancer combination therapies

Dawson, J. C., Serrels, A., Stupack, D. G., Schlaepfer, D. D., & Frame, M. C. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00340-6 · Cited by 397 · see citing works

Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin–integrin interactions using recombinant α3β1, α6β1, α7β1 and α6β4 integrins

Nishiuchi, R., Takagi, J., Hayashi, M., Ido, H., Yagi, Y., Sanzen, N., Tsuji, T., Yamada, M., & Sekiguchi, K. (2006) · Matrix Biology · doi:10.1016/j.matbio.2005.12.001 · Cited by 385 · see citing works

Hyaluronan Receptor LYVE-1-Expressing Macrophages Maintain Arterial Tone through Hyaluronan-Mediated Regulation of Smooth Muscle Cell Collagen

Lim, H. Y., Lim, S. Y., Tan, C. K., Thiam, C. H., Goh, C. C., Carbajo, D., Chew, S. H. S., See, P., Chakarov, S., Wang, X. N., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.008 · Cited by 384 · see citing works

Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics

Nam, A. S., Chaligné, R., & Landau, D. A. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0265-5 · Cited by 381 · see citing works

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Saatci, Ö., Kaymak, A., Raza, U., Ersan, P. G., Akbulut, Ö., Banister, C. E., Sikirzhytski, V., Tokat, Ü. M., Aykut, G., Ansari, S. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16199-4 · Cited by 373 · see citing works

Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts

Bhattacharjee, S., Hamberger, F., Ravichandra, A., Miller, M., Nair, A., Affo, S., Filliol, A., Chin, L., Savage, T. M., Yin, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146987 · Cited by 367 · see citing works

The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis

Ray, J., & Stetler‐Stevenson, W. G. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07112062 · Cited by 360 · see citing works

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin

Borsi, L., Balza, E., Bestagno, M., Castellani, P., Carnemolla, B., Biro, A., Leprini, A., Sepúlveda, J., Burrone, Ó. R., Neri, D., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10662 · Cited by 354 · see citing works

Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system

Huang, G., & Huang, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.015 · Cited by 354 · see citing works

Basement membranes

Jayadev, R., & Sherwood, D. R. (2017) · Current Biology · doi:10.1016/j.cub.2017.02.006 · Cited by 353 · see citing works

Emerging roles of ECM remodeling processes in cancer

Mohan, V., Das, A., & Sagi, I. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.004 · Cited by 339 · see citing works

Lysyl oxidases: from enzyme activity to extracellular matrix cross-links

Vallet, S. D., & Ricard‐Blum, S. (2019) · Essays in Biochemistry · doi:10.1042/ebc20180050 · Cited by 338 · see citing works

Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors

Zinger, A., Koren, L., Adir, O., Poley, M., Alyan, M., Yaari, Z. A., Noor, N., Krinsky, N., Simon, A., Gibori, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b02395 · Cited by 327 · see citing works

Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration

Frost, G. I. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.427 · Cited by 323 · see citing works

The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesis

Castellani, P., Viale, G., Dorcaratto, A., Nicolò, G., Kaczmarek, J., Querzé, G., & Zardi, L. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590507 · Cited by 312 · see citing works

Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy

Zhou, H., Fan, Z., Deng, J., Lemons, P. K., Arhontoulis, D. C., Bowne, W. B., & Cheng, H. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00820 · Cited by 294 · see citing works

Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins

Zeltz, C., Primac, I., Erusappan, P., Alam, J., Noel, A., & Gullberg, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.004 · Cited by 290 · see citing works

Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis

Chen, W., Yang, A., Jia, J., Popov, Y. V., Schuppan, D., & You, H. (2020) · Hepatology · doi:10.1002/hep.31236 · Cited by 284 · see citing works

MMP-Responsive ‘Smart’ Drug Delivery and Tumor Targeting

Yao, Q., Kou, L., Tu, Y., & Zhu, L. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.06.003 · Cited by 283 · see citing works

ADAMTS proteins in human disorders

Mead, T. J., & Apte, S. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.06.002 · Cited by 281 · see citing works

The fibrotic tumor stroma

Yamauchi, M., Barker, T. H., Gibbons, D. L., & Kurie, J. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93554 · Cited by 273 · see citing works

Strategies to improve tumor penetration of nanomedicines through nanoparticle design

Zhang, Y., Lin, R., Li, H., He, W., Du, J., & Wang, J. (2018) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1519 · Cited by 269 · see citing works

Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors

Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 264 · see citing works

MMP generated matrikines

Wells, J. M., Gaggar, A., & Blalock, J. E. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.016 · Cited by 263 · see citing works

A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome

Ori, A., Wilkinson, M. C., & Fernig, D. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228114 · Cited by 251 · see citing works

Fibronectin as target for tumor therapy

Kaspar, M., Zardi, L., & Neri, D. (2005) · International Journal of Cancer · doi:10.1002/ijc.21677 · Cited by 248 · see citing works

Collagen interactions: Drug design and delivery

An, B., Lin, Y., & Brodsky, B. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.013 · Cited by 245 · see citing works

Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition

Park, J., & Schwarzbauer, J. E. (2013) · Oncogene · doi:10.1038/onc.2013.118 · Cited by 243 · see citing works

Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy

Zhang, D., Wang, G., Yu, X., Wei, T., Farbiak, L., Johnson, L. T., Taylor, A. M., Xu, J., Hong, Y., Zhu, H., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01122-3 · Cited by 243 · see citing works

Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy

Musetti, S., & Huang, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b05893 · Cited by 239 · see citing works

Heparanase: From basic research to therapeutic applications in cancer and inflammation

Vlodavsky, I., Singh, P., Boyango, I., Gutter-Kapon, L., Elkin, M., Sanderson, R. D., & Ilan, N. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.10.001 · Cited by 237 · see citing works

Immune Modulatory Properties of Collagen in Cancer

Rømer, A. M. A., Thorseth, M., & Madsen, D. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791453 · Cited by 231 · see citing works

Targeting the Tumor Microenvironment in Cancer: Why Hyaluronidase Deserves a Second Look

Whatcott, C. J., Han, H., Posner, R. G., Hostetter, G. H., & Hoff, D. D. V. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0136 · Cited by 224 · see citing works

Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins

Vedadghavami, A., Zhang, C., & Bajpayee, A. G. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100898 · Cited by 213 · see citing works

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy

Huang, J., Xiao, Z., An, Y., Han, S., Wu, W., Wang, Y., Guo, Y., & Shuai, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120636 · Cited by 210 · see citing works

Integrin Signaling in Cancer Cell Survival and Chemoresistance

Aoudjit, F., & Vuori, K. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/283181 · Cited by 207 · see citing works

Covalently immobilized laminin peptide Tyr-Ile-Gly-Ser-Arg (YIGSR) supports cell spreading and co-localization of the 67-kilodalton laminin receptor with alpha-actinin and vinculin.

Massia, S. P., Rao, S. S., & Hubbell, J. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53062-3 · Cited by 195 · see citing works

Collagen mimetic peptide-conjugated photopolymerizable PEG hydrogel

Lee, H. J., Lee, J. S., Chansakul, T., Yu, C. K., Elisseeff, J. H., & Yu, S. M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.06.001 · Cited by 195 · see citing works

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

Arabi, L., Badiee, A., Mosaffa, F., & Jaafari, M. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.044 · Cited by 183 · see citing works

A Tumor Microenvironments‐Adapted Polypeptide Hydrogel/Nanogel Composite Boosts Antitumor Molecularly Targeted Inhibition and Immunoactivation

Li, Z., Xu, W., Yang, J.-Z., Wang, J., Wang, J., Zhu, G., Li, D., Ding, J., & Sun, T. (2022) · Advanced Materials · doi:10.1002/adma.202200449 · Cited by 181 · see citing works

Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology

Spada, S., Tocci, A., Modugno, F. D., & Nisticò, P. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01908-8 · Cited by 180 · see citing works

Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix

Kay, E. J., Paterson, K., Riera‐Domingo, C., Sumpton, D. P., Däbritz, J. H. M., Tardito, S., Boldrini, C., Hernandez-Fernaud, J. R., Athineos, D., Dhayade, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00582-0 · Cited by 180 · see citing works

Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma

Ruan, S., He, Q., & Gao, H. (2015) · Nanoscale · doi:10.1039/c5nr01408e · Cited by 175 · see citing works

Regulatory T cells promote cancer immune-escape through integrin αvβ8-mediated TGF-β activation

Lainé, A., Labiad, O., Hernández‐Vargas, H., This, S., Sanlaville, A., Goddard‐Léon, S., Dalle, S., Sheppard, D., Travis, M. A., Païdassi, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26352-2 · Cited by 173 · see citing works

Hyperproduction of Hyaluronan in Neu-Induced Mammary Tumor Accelerates Angiogenesis through Stromal Cell Recruitment

Koyama, H., Hibi, T., Isogai, Z., Yoneda, M., Fujimori, M., Amano, J., Kawakubo, M., Kannagi, R., Kimata, K., Taniguchi, S., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060793 · Cited by 170 · see citing works

The extracellular matrix viscoelasticity as a regulator of cell and tissue dynamics

Elosegui-Artola, A. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2021.04.002 · Cited by 170 · see citing works

Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression

Wei, J., Hu, M., Huang, K., Lin, S., & Du, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175983 · Cited by 169 · see citing works

Collagenase: a key enzyme in collagen turnover

Shingleton, W. D., Cawston, T. E., Hodges, D. J., & Brick, P. (1996) · Biochemistry and Cell Biology · doi:10.1139/o96-083 · Cited by 166 · see citing works

The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin

Pontiggia, O., Sampayo, R. G., Raffo, D., Motter, A. N., Xu, R., Bissell, M. J., Joffé, E. B. D. K., & Simian, M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1766-x · Cited by 166 · see citing works

Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance

Fidoamore, A., Cristiano, L., Antonosante, A., d’Angelo, M., Giacomo, E. D., Astarita, C., Giordano, A., Ippoliti, R., Benedetti, E., & Cimini, A. (2016) · Stem Cells International · doi:10.1155/2016/6809105 · Cited by 163 · see citing works

To form and function: on the role of basement membrane mechanics in tissue development, homeostasis and disease

Khalilgharibi, N., & Mao, Y. (2021) · Open Biology · doi:10.1098/rsob.200360 · Cited by 159 · see citing works

Cancer Epigenetics: An Overview

Targa, F. R. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.11.003 · Cited by 157 · see citing works

Structurally Defined Nanoscale Sheets from Self-Assembly of Collagen-Mimetic Peptides

Jiang, T., Xu, C., Liu, Y., Liu, Z., Wall, J. S., Zuo, X., Lian, T. T., Salaita, K. S., Ni, C., Pochan, D. J., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412867z · Cited by 153 · see citing works

Extracellular matrix physical properties govern the diffusion of nanoparticles in tumor microenvironment

He, X., Yang, Y., Han, Y., Cao, C., Zhang, Z., Li, L., Xiao, C., Guo, H., Wang, L., Han, L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209260120 · Cited by 153 · see citing works

The 67 kDa laminin receptor as a prognostic factor in human cancer

Ménard, S., Tagliabue, E., & COLNAGHI, M. I. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006171403765 · Cited by 152 · see citing works

Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting

Chen, K., Xie, J., Xu, H., Behera, D., Michalski, M. H., Biswal, S., Wang, A., & Chen, X. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.045 · Cited by 150 · see citing works

Glycosaminoglycan-Protein Interactions and Their Roles in Human Disease

Shi, D., Sheng, A., & Chi, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.639666 · Cited by 150 · see citing works

Immunotoxicity of metal and metal oxide nanoparticles: from toxic mechanisms to metabolism and outcomes

Bi, J., Mo, C., Li, S., Huang, M., Lin, Y., Yuan, P., Liu, Z., Jia, B., & Xu, S. (2023) · Biomaterials Science · doi:10.1039/d3bm00271c · Cited by 149 · see citing works

Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy

Falcone, I., Conciatori, F., Bazzichetto, C., Ferretti, G., Cognetti, F., Ciuffreda, L., & Milella, M. (2020) · Cancers · doi:10.3390/cancers12102870 · Cited by 147 · see citing works

Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response

Alexander, S., Weigelin, B., Winkler, F., & Friedl, P. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.001 · Cited by 145 · see citing works

Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis

Yuzhalin, A. E., Lim, S. Y., Kutikhin, A. G., & Gordon-Weeks, A. N. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.09.002 · Cited by 144 · see citing works

Fibronectin-targeted drug delivery in cancer

Kumra, H., & Reinhardt, D. P. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.014 · Cited by 140 · see citing works

Targeting collagen for diagnostic imaging and therapeutic delivery

Wahyudi, H., Reynolds, A. A., Li, Y., Owen, S. C., & Yu, S. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.007 · Cited by 134 · see citing works

Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain

Dai, J., Cimino, P. J., Gouin, K. H., Grzelak, C. A., Barrett, A. S., Lim, A. R., Long, A., Weaver, S., Saldin, L. T., Uzamere, A., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00297-3 · Cited by 134 · see citing works

A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles

Cai, J., Fu, J., Li, R., Zhang, F., Ling, G., & Zhang, P. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.12.074 · Cited by 126 · see citing works

The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence.

Carnemolla, B., Leprini, A., Allemanni, G., Saginati, M., & Zardi, L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35819-8 · Cited by 125 · see citing works

Basement membrane collagens and disease mechanisms

Gatseva, A., Sin, Y. Y., Brezzo, G., & Agtmael, T. V. (2019) · Essays in Biochemistry · doi:10.1042/ebc20180071 · Cited by 125 · see citing works

Inhibition of Mammary Tumor Growth Using Lysyl Oxidase-Targeting Nanoparticles to Modify Extracellular Matrix

Kanapathipillai, M., Mammoto, A., Mammoto, T., Kang, J. H., Jiang, E., Ghosh, K., Korin, N., Gibbs, A. D., Mannix, R. J., & Ingber, D. E. (2012) · Nano Letters · doi:10.1021/nl301206p · Cited by 122 · see citing works

Improving nanoparticle diffusion through tumor collagen matrix by photo-thermal gold nanorods

Raeesi, V., & Chan, W. C. W. (2016) · Nanoscale · doi:10.1039/c5nr08463f · Cited by 122 · see citing works

Cancer‐associated fibroblast‐derived Lumican promotes gastric cancer progression via the integrin β1‐FAK signaling pathway

Wang, X., Zhou, Q., Yu, Z., Wu, X., Chen, X., Li, J., Li, C., Yan, M., Zhu, Z., Liu, B., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30801 · Cited by 117 · see citing works

The Plot Thickens: The Emerging Role of Matrix Viscosity in Cell Mechanotransduction

Cantini, M., Donnelly, H., Dalby, M. J., & Salmerón‐Sánchez, M. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901259 · Cited by 116 · see citing works

Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy

Zhang, T., Jia, Y., Yu, Y., Zhang, B., Xu, F., & Guo, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114319 · Cited by 116 · see citing works

Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance

Krisnawan, V. E., Stanley, J. A., Schwarz, J. K., & DeNardo, D. G. (2020) · Cancers · doi:10.3390/cancers12102916 · Cited by 114 · see citing works

TGF-β3 Stimulates and Regulates Collagen Synthesis Through TGF-β1-Dependent and Independent Mechanisms

Murata, H., ZHOU, L. H., Ochoa, S., Hasan, A., Badiavas, E. V., & Falanga, V. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12286451 · Cited by 113 · see citing works

Interstitial fluid pressure as an emerging biomarker in solid tumors

Salavati, H., Debbaut, C., Pullens, P., & Ceelen, W. P. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188792 · Cited by 112 · see citing works

A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor αvβ3 Integrin Receptors Reveals Cyclic RGD as A Double‐Edged Sword

Shuhendler, A. J., Prasad, P., Leung, M. Y. K., Rauth, A. M., DaCosta, R. S., & Wu, X. Y. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200006 · Cited by 111 · see citing works

Laminin 5 processing and its integration into the ECM

Aumailley, M., ELKHAL, A., Knöß, N., & Tunggal, L. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00013-1 · Cited by 111 · see citing works

Endosomes: Emerging Platforms for Integrin-Mediated FAK Signalling

Alanko, J., & Ivaska, J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.02.001 · Cited by 110 · see citing works

Autophagy regulates cisplatin‐induced stemness and chemoresistance via the upregulation of CD 44, ABCB 1 and ADAM 17 in oral squamous cell carcinoma

Naik, P. P., Mukhopadhyay, S., Panda, P. K., Sinha, N., Das, C. K., Mishra, R., Patil, S., & Bhutia, S. K. (2017) · Cell Proliferation · doi:10.1111/cpr.12411 · Cited by 110 · see citing works

Role of cell surface proteoglycans in cancer immunotherapy

Espinoza‐Sánchez, N. A., & Götte, M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.012 · Cited by 108 · see citing works

Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin‐332/α3 integrin axis recovery of focal adhesion kinase ubiquitination

Azzariti, A., Mancarella, S., Porcelli, L., Quatrale, A. E., Caligiuri, A., Lupo, L., Dituri, F., & Giannelli, G. (2016) · Hepatology · doi:10.1002/hep.28835 · Cited by 106 · see citing works

Marimastat: the clinical development of a matrix metalloproteinase inhibitor

Thomas, A., & Steward, W. P. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.12.2913 · Cited by 105 · see citing works

Intraperitoneal Immunotherapy for Metastatic Ovarian Carcinoma: Resistance of Intratumoral Collagen to Antibody Penetration

Choi, J., Credit, K., Henderson, K., Deverkadra, R., He, Z., Wiig, H., Vanpelt, H. M., & Flessner, M. F. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2141 · Cited by 104 · see citing works

Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles

Zhang, B., Shen, S., Liao, Z., Shi, W., Wang, Y., Zhao, J., Hu, Y., Yang, J., Chen, J., Mei, H., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.046 · Cited by 101 · see citing works

Direct Detection of Collagenous Proteins by Fluorescently Labeled Collagen Mimetic Peptides

Li, Y., Ho, D., Meng, H., Chan, T. R., An, B., Yu, H., Brodsky, B., Jun, A. S., & Yu, S. M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc3005842 · Cited by 101 · see citing works

Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis

Cavaco, A. C. M., Dâmaso, S., Casimiro, S., & Costa, L. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09888-5 · Cited by 101 · see citing works

Hyaluronic Acid: Known for Almost a Century, but Still in Vogue

Lierová, A., Kašparová, J., Filipová, A., Čížková, J., Pekarova, L., Korecká, L., Mannová, N., Bı́lková, Z., & Šinkorová, Z. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040838 · Cited by 98 · see citing works

Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment

Yokoi, K., Kojic, M., Milosevic, M., Tanei, T., Ferrari, M., & Ziemys, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3494 · Cited by 95 · see citing works

Nanoparticle mediated cancer immunotherapy

Gupta, J., Safdari, H. A., & Hoque, M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.015 · Cited by 94 · see citing works

Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment

Song, K., Yu, Z., Zu, X., Li, G., Hu, Z., & Xue, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810509 · Cited by 91 · see citing works

NF-κB Regulates Radioresistance Mediated By β1-Integrin in Three-Dimensional Culture of Breast Cancer Cells

Ahmed, K. M., Zhang, H., & Park, C. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3537 · Cited by 90 · see citing works

Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression

Donelan, W., Dominguez‐Gutierrez, P. R., & Kusmartsev, S. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.971278 · Cited by 90 · see citing works

Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy

Ye, M., Song, Y., Pan, S., Chu, M., Wang, Z. P., & Zhu, X. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107633 · Cited by 89 · see citing works

Role of the extracellular matrix in cancer‐associated epithelial to mesenchymal transition phenomenon

Tzanakakis, G. N., Kavasi, R., Voudouri, K., Berdiaki, A., Spyridaki, I., Tsatsakis, A. M., & Nikitovic, D. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24557 · Cited by 88 · see citing works

Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin

Sarfati, G., Dvir, T., Elkabets, M., Apte, R. N., & Cohen, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.014 · Cited by 88 · see citing works

Laminins and cancer stem cells: Partners in crime?

Qin, Y., Rodin, S., Simonson, O. E., & Hollande, F. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.07.004 · Cited by 87 · see citing works

ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance

Conrad, C., Benzel, J., Dorzweiler, K., Cook, L., Schlomann, U., Zarbock, A., Slater, E. P., Nimsky, C., & Bartsch, J. W. (2019) · Clinical Science · doi:10.1042/cs20180906 · Cited by 86 · see citing works

Cell Adhesion to Fibronectin (CAM-DR) Influences Acquired Mitoxantrone Resistance in U937 Cells

Hazlehurst, L., Argilagos, R. F., Emmons, M. F., Boulware, D. C., Beam, C. A., Sullivan, D. M., & Dalton, W. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3256 · Cited by 84 · see citing works

Transformable Nanoparticle‐Enabled Synergistic Elicitation and Promotion of Immunogenic Cell Death for Triple‐Negative Breast Cancer Immunotherapy

Xu, C., Yu, Y., Sun, Y., Kong, L., Yang, C., Hu, M. Y., Yang, T., Zhang, J., Hu, Q., & Zhang, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201905213 · Cited by 84 · see citing works

Laminin γ2–mediating T cell exclusion attenuates response to anti–PD-1 therapy

Li, L., Wei, J.-R., Dong, J., Lin, Q., Tang, H., Jia, Y., Tan, W., Chen, Q., Zeng, T., Xing, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc8346 · Cited by 84 · see citing works

Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma

Jerhammar, F., Ceder, R., Garvin, S., Grenman, R. A., Grafström, R. C., & Roberg, K. B. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.13432 · Cited by 81 · see citing works

Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1

Vijver, S. V., Singh, A., Elshof, E., Meeldijk, J., Copeland, R. J., Boon, L., Langermann, S., Flies, D. B., Meyaard, L., & Ramos, M. I. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733561 · Cited by 80 · see citing works

Mechanosensitive ion channels in cell migration

Coutiño, B. C., & Mayor, R. (2021) · Cells and Development · doi:10.1016/j.cdev.2021.203683 · Cited by 79 · see citing works

Culture on 3D Chitosan‐Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells

Wang, K., Kievit, F. M., Erickson, A. E., Silber, J. R., Ellenbogen, R. G., & Zhang, M. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600684 · Cited by 78 · see citing works

ADAM proteases: Emerging role and targeting of the non-catalytic domains

Saha, N., Tzvetkova‐Robev, D., Himanen, J. P., & Nikolov, D. B. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.003 · Cited by 78 · see citing works

Extracellular Matrix Limits Nanoparticle Diffusion and Cellular Uptake in a Tissue-Specific Manner

Cahn, D., Stern, A., Buckenmeyer, M. J., Wolf, M. T., & Duncan, G. A. (2024) · ACS Nano · doi:10.1021/acsnano.4c10381 · Cited by 78 · see citing works

ADAM-Integrin Interactions: Potential Integrin Regulated Ectodomain Shedding Activity

Bridges, L. C., & Bowditch, R. D. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381747 · Cited by 77 · see citing works

Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk

Sun, T., Patil, R., Galstyan, A., Klymyshyn, D., Ding, H., Chesnokova, A., Cavenee, W. K., Furnari, F. B., Ljubimov, V. A., Shatalova, E. S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2725 · Cited by 77 · see citing works

Peptide-Based Nanoparticles Mimic Fibrillogenesis of Laminin in Tumor Vessels for Precise Embolization

Zhang, K., Yang, P., He, P.-P., Wen, S.-F., Zou, X.-R., Fan, Y., Chen, Z., Cao, H., Yang, Z., Yue, K., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c02110 · Cited by 77 · see citing works

Targeting tumor interstitial fluid pressure: will it yield novel successful therapies for solid tumors?

Boeckelmann, L., & Schumacher, U. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702974 · Cited by 76 · see citing works

pH/reduction dual-responsive hyaluronic acid-podophyllotoxin prodrug micelles for tumor targeted delivery

Li, M., Zhao, Y., Sun, J., Chen, H., Liu, Z., Lin, K., Ma, P., Zhang, W., Zhen, Y., Zhang, S., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119402 · Cited by 75 · see citing works

Targeted Drug Delivery via the Use of ECM-Mimetic Materials

Hwang, J., Sullivan, M. O., & Kiick, K. L. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00069 · Cited by 74 · see citing works

Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer

Vita, A. D., Liverani, C., Molinaro, R., Martinez, J. O., Hartman, K. A., Spadazzi, C., Miserocchi, G., Taraballi, F., Evangelopoulos, M., Pieri, F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84492-3 · Cited by 74 · see citing works

Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer

Gong, Z., Chen, M., Ren, Q., Yue, X., & Dai, Z. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0104-3 · Cited by 73 · see citing works

Recent Advances in Collagen Mimetic Peptide Structure and Design

Hulgan, S. A. H., & Hartgerink, J. D. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00028 · Cited by 73 · see citing works

Targeting type I collagen for cancer treatment

Shi, R., Zhang, Z., Zhu, A.-K., Xiong, X., Zhang, J., Xu, J., Sy, M., & Li, C. (2022) · International Journal of Cancer · doi:10.1002/ijc.33985 · Cited by 71 · see citing works

huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models

Lo, K.-M., Yan, L., Lauder, S., Zhang, J., Brunkhorst, B. A., Qin, G., Verma, R., Courtenay-Luck, N. S., & Gillies, S. D. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0203-1 · Cited by 70 · see citing works

Reconstituted collagen nanoparticles, a novel drug carrier delivery system

El-Samaligy, M. S., & Rohdewald, P. J. (1983) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1983.tb04831.x · Cited by 70 · see citing works

ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma

Arechederra, M., Bazai, S. K., Abdouni, A., Sequera, C., Mead, T. J., Richelme, S., Daian, F., Audebert, S., Dono, R., Lozano, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.008 · Cited by 70 · see citing works

Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis

Twarock, S., Freudenberger, T., Poscher, E. R. G., Dai, G., Jannasch, K., Dullin, C., Alves, F., Prenzel, K., Knoefel, W. T., Stoecklein, N. H., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-30 · Cited by 69 · see citing works

Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy

Cheng, T.-M., Chang, W.-J., Chu, H.-Y., Luca, R. D., Pedersen, J. Z., Incerpi, S., Li, Z., Shih, Y.-J., Lin, H., Wang, K., et al. (2021) · Cells · doi:10.3390/cells10071684 · Cited by 68 · see citing works

An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer

Sun, Y., Lyu, B., Yang, C. Q., He, B., Zhang, H., Wang, X., Zhang, Q., & Dai, W. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.08.020 · Cited by 65 · see citing works

Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain®in human tumour and normal cellsin vitro

Cordes, N., Bläse, M., Plaßwilm, L., Rodemann, H. P., & Beuningen, D. V. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001610240 · Cited by 65 · see citing works

Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics

Yang, C., Li, S., & Wang, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02443-2 · Cited by 50 · see citing works

Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape

Salgado-Pascual, A., Zalba, S., Lasarte, J. J., & Garrido, M. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115760 · Cited by 15 · see citing works

STAR Therapy: Spatiotemporal Antitumor Regimen via a Size‐Gated DNA Hydrogel Drug Delivery System

Feng, C. Q., Yang, Z., Lan, Y., Fu, X., Zhang, W., Lu, W., Huang, Z., Wang, Y., Zhang, Z., Fan, J., et al. (2026) · Advanced Materials · doi:10.1002/adma.202517487 · Cited by 8 · see citing works

Matrix mechanical remodeled carrier-free nanosystem for programmable closed-loop reversal of liver fibrosis via STING alkylation

Han, H., Yu, D., Liu, Y., Jia, H., & Liu, W. (2025) · Science Advances · doi:10.1126/sciadv.adz4126 · Cited by 7 · see citing works

Engineering Nanoparticles to Modulate Extracellular Matrix and Immune Components of the Tumor Microenvironment in Cancer Immunotherapy

Dang, B.-T. N., Pham, K., Nguyen, A.-H., Park, J., Kwon, T. K., Kang, J., Jeong, J., & Yook, S. (2025) · Biomaterials Research · doi:10.34133/bmr.0289 · Cited by 7 · see citing works

Deciphering Apolipoprotein A4 in the Protein Corona of Ligand-Modified Liposomes for Tumor Targeting and Penetration

Liang, Y. I. X. I. U., Li, X., Zhang, Y., Ding, X., 聂为民, Wang, S., Huang, M., Wu, Y., Wu, S., Zhao, X., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c19739 · Cited by 7 · see citing works

The Stiff Side of Cancer: How Matrix Mechanics Rewrites Non-Coding RNA Expression Programs

Campos-Parra, A. D., Puente-Rivera, J., López‐Camarillo, C., Núñez-Olvera, S. I., Nava, N. H., Macías, G. A., & Silva-Cázares, M. B. (2026) · Non-Coding RNA · doi:10.3390/ncrna12010007 · Cited by 5 · see citing works

Nanomedicine-enabled in situ vaccination: Advancing a trilogy of immunogenic cell death induction, antigen presentation potentiation, and microenvironment remodeling

Li, Z., Zhang, H., & Wang, R. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124364 · Cited by 5 · see citing works

Targeting the extracellular matrix in precision medicine: opportunities for diagnostics and therapeutics

Nelluri, K. D. D., Lakshmi, K. C., Kommoju, M., Alaparthi, B., Kakani, A. K., Rohith, P. S., & Nirmala, N. V. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11624-1 · Cited by 3 · see citing works

Engineering spatially defined extracellular matrix gradients to govern self-organized multicellular aggregates in a glioblastoma-on-a-chip

Li, J., Gao, X., Yang, X., Wang, H., Sun, X., Xue, C., & Ma, J. (2025) · Lab on a Chip · doi:10.1039/d5lc01018g · Cited by 2 · see citing works

Enzyme-based nanomedicine for tumor microenvironment modulation in cancer therapy

Ta, Y. N., Wang, S.-N., & Chen, Y. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115101 · Cited by 2 · see citing works

Innovations in peptide-based targeted therapies for breast cancer: From conjugates to precision delivery

Ghazani, N. D., Shojaei, A., Rahbarnia, L., Safary, A., Akbarzadeh‑Khiavi, M., & Nabizadeh, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119707 · Cited by 2 · see citing works

Advancing precision tumor therapy: Progress in targeted delivery of peptide-based nanomaterials from microenvironment to organelles

Tian, K., Sheng, J., Chen, J., Zhang, M., Song, J., Wu, M., Zhao, Y., & Zhang, S. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102820 · Cited by 1 · see citing works

Nano meets CAR-T: A new era in cancer immunotherapy

Ibrahim, A., & Nasr, M. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189685 · Cited by 1 · see citing works

When ‘Dirty’ Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer Drugs

Marchiò, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052400

Green synthesis and functionalization of gold nanoparticles: Implications for anticancer therapy and biomedical applications

Santhiya, S., & Sankarganesh, M. (2026) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2026.117334

Type I collagen matrix signaling in cancer: receptor sensing and mechanotransduction

Xiao, X., Yu, P., Liu, Y., Zhou, Z., Zhao, K., Li, W., Li, Z., Ma, L., Wang, Y., Zhang, Y., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112853

Multifunctional biomaterial nanocarriers for gene-chemotherapeutic co-delivery: molecular mechanisms, design strategies and clinical translation in precision cancer therapy

Satapathy, T., Satapathy, A., Sahu, P., & Satapathy, A. (2026) · Biomaterials and Living Medicine for Pharmaceutics · doi:10.1016/j.bioliv.2026.100011

Advancements in polymer-based drug delivery systems targeting the tumor microenvironment for immunotherapy of triple-negative breast cancer

Wang, Z., Li, M., Wang, Z., & Wang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1927103

Precision Nanomedicine Requires Matching Carrier Adaptation to Disease Microenvironment Dynamics

Wilson, G., Bennett, C., Wright, E., & Turner, J. (2026) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/ixikkehlj0

Engineering extracellular matrix to improve drug delivery for cancer therapy

He, X., Yang, Y., Li, L., Zhang, P., Guo, H., Liu, N., Yang, X., & Xu, F. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.06.029 · Cited by 54 · see citing works

Unraveling the Role of the Tumor Extracellular Matrix to Inform Nanoparticle Design for Nanomedicine

Cassani, M., Fernandes, S., Pagliari, S., Cavalieri, F., Caruso, F., & Forte, G. (2024) · Advanced Science · doi:10.1002/advs.202409898 · Cited by 49 · see citing works

Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles

Muhammad, F. A., Altalbawy, F. M. A., Mandaliya, V. B., Saraswat, S. K., Rekha, M. M., Aulakh, D., Chahar, M., Mahdi, M. S., Jaber, M., & Alhadrawi, M. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03793-x · Cited by 3 · see citing works

Cancer therapy based on extracellular matrix

Gaikwad, S., Patil, A., Jha, A., & Sharma, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44185-1.00013-6

Extracellular matrix: unlocking new avenues in cancer treatment

Lee, J. J., Ng, K. Y., & Bakhtiar, A. (2025) · Biomarker Research · doi:10.1186/s40364-025-00757-3 · Cited by 76 · see citing works